154 related articles for article (PubMed ID: 38622555)
1. Prognostic value of pre-treatment [
Dong Z; Wang GY; Dai DY; Qin GJ; Tang LL; Xu C; Ma J
BMC Cancer; 2024 Apr; 24(1):466. PubMed ID: 38622555
[TBL] [Abstract][Full Text] [Related]
2. Head and neck MRI-based T stage and [
Xie HJ; Sun XS; Zhang X; Xiao BB; Lin DF; Lin XP; Lv XF; Liu LZ; Han F; Zou RH; Li JB; Fan W; Chen QY; Mai HQ; Tang LQ
Eur Radiol; 2023 Nov; 33(11):7952-7966. PubMed ID: 37314471
[TBL] [Abstract][Full Text] [Related]
3. Survival effect of pretreatment FDG-PET-CT on nasopharyngeal cancer.
Yang PC; Chen WM; Chen M; Shia BC; Wu SY; Chiang CW
J Formos Med Assoc; 2023 Jan; 122(1):36-46. PubMed ID: 35999158
[TBL] [Abstract][Full Text] [Related]
4. Prediction of outcomes in patients with local recurrent nasopharyngeal carcinoma: development and validation of a four-factor prognostic model integrating baseline characteristics and [
Dongxiang W; Liting L; Yujing L; Meijuan L; Shanshan G; Longbin X; Yanzhou C; Meiling C; Kang N; Haiqiang M; Linquan T; Qiuyan C
Eur Radiol; 2023 Apr; 33(4):2840-2849. PubMed ID: 36422647
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
Zschaeck S; Li Y; Lin Q; Beck M; Amthauer H; Bauersachs L; Hajiyianni M; Rogasch J; Ehrhardt VH; Kalinauskaite G; Weingärtner J; Hartmann V; van den Hoff J; Budach V; Stromberger C; Hofheinz F
PLoS One; 2020; 15(7):e0236841. PubMed ID: 32730364
[TBL] [Abstract][Full Text] [Related]
6. Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Xiao BB; Chen QY; Sun XS; Li JB; Luo DH; Sun R; Lin DF; Zhang X; Fan W; Lv XF; Han LJ; Wen YF; Yuan L; Guo SS; Liu LT; Liu SL; Tang QN; Liang YJ; Li XY; Lin C; Guo L; Mai HQ; Tang LQ
Eur Radiol; 2021 Jul; 31(7):5222-5233. PubMed ID: 33416977
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment [
Gihbid A; Cherkaoui Salhi G; El Alami I; Belgadir H; Tawfiq N; Bendahou K; El Mzibri M; Cadi R; El Benna N; Guensi A; Khyatti M
Ann Nucl Med; 2022 Oct; 36(10):876-886. PubMed ID: 35836088
[TBL] [Abstract][Full Text] [Related]
8. Benefit of [
OuYang PY; Liu ZQ; Lin QG; He Y; Guo ZX; Yao WY; Xu SK; Peng QH; Xiao SM; Li J; Li A; Zhang BY; Yang SS; Fan W; Xie CM; Wu YS; Zhang X; Chen CY; Xie FY
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):881-891. PubMed ID: 36301324
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.
Chan SC; Yen TC; Ng SH; Lin CY; Wang HM; Liao CT; Fan KH; Chang JT
J Nucl Med; 2006 Sep; 47(9):1447-54. PubMed ID: 16954552
[TBL] [Abstract][Full Text] [Related]
10. Selectively recommend
Chen C; Xu T; Qiu X; Xie S; You Z; Hu Y; Zheng Y; Liang Z; Huang C; Chen T; Li L; Liu J; Fei Z
Radiat Oncol; 2021 Nov; 16(1):229. PubMed ID: 34838075
[TBL] [Abstract][Full Text] [Related]
11. PET/CT standardized uptake value and EGFR expression predicts treatment failure in nasopharyngeal carcinoma.
Fei Z; Xu T; Hong H; Xu Y; Chen J; Qiu X; Ding J; Huang C; Li L; Liu J; Chen C
Radiat Oncol; 2023 Feb; 18(1):33. PubMed ID: 36814303
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of [
Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of the post-radiotherapy
Jeong Y; Jung IH; Kim JS; Chang SK; Lee SW
Br J Radiol; 2019 Oct; 92(1102):20180045. PubMed ID: 30102562
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
Yoon HI; Kim KH; Lee J; Roh YH; Yun M; Cho BC; Lee CG; Keum KC
Cancer Res Treat; 2016 Jul; 48(3):928-41. PubMed ID: 26693913
[TBL] [Abstract][Full Text] [Related]
15. Value of early evaluation of treatment response using
Chen YH; Chang KP; Chu SC; Yen TC; Wang LY; Chang JT; Hsu CL; Ng SH; Liu SH; Chan SC
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):650-660. PubMed ID: 30264225
[TBL] [Abstract][Full Text] [Related]
16. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Lin KJ; Lin WJ; Fu YK; Lin CY
J Nucl Med; 2005 Mar; 46(3):405-10. PubMed ID: 15750151
[TBL] [Abstract][Full Text] [Related]
17. Different prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrence.
Shen T; Tang LQ; Luo DH; Chen QY; Li PJ; Mai DM; Guo SS; Liu LT; Qian CN; Guo X; Zeng MS; Mo HY; Mai HQ
PLoS One; 2015; 10(4):e0122756. PubMed ID: 25853677
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
[TBL] [Abstract][Full Text] [Related]
19. Whole-body
Ren YY; Li YC; Wu HB; Wang QS; Han YJ; Zhou WL; Li HS
Eur J Radiol; 2017 Apr; 89():200-207. PubMed ID: 28267540
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of primary gross tumor volume and standardized uptake value of
Jin YN; Yao JJ; Wang SY; Zhang WJ; Zhou GQ; Zhang F; Cheng ZB; Ma J; Mo HY; Sun Y
Tumour Biol; 2017 Jul; 39(7):1010428317717843. PubMed ID: 28671052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
